guanidine has been researched along with Melanoma in 3 studies
Guanidine: A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.
guanidine : An aminocarboxamidine, the parent compound of the guanidines.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Baladi, T | 1 |
Hamouda-Tekaya, N | 1 |
Gonçalves, LCP | 1 |
Rocchi, S | 1 |
Ronco, C | 1 |
Benhida, R | 1 |
Shete, H | 1 |
Sable, S | 1 |
Tidke, P | 1 |
Selkar, N | 1 |
Pawar, Y | 1 |
Chakraborty, A | 1 |
De, A | 1 |
Vanage, G | 1 |
Patravale, V | 1 |
McDonald, JF | 1 |
Dimitry, JM | 1 |
Frazier, WA | 1 |
3 other studies available for guanidine and Melanoma
Article | Year |
---|---|
Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationsh | 2020 |
Mono-guanidine heterolipid based SMEDDS: A promising tool for cytosolic delivery of antineoplastics.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cell Proliferation; Drug | 2015 |
An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs.
Topics: Amino Acid Motifs; Amino Acid Sequence; Amyloid; Antigens, CD; Benzothiazoles; Carrier Proteins; CD4 | 2003 |